Fig. 7From: Characterization of the fatty acid metabolism-related genes in lung adenocarcinoma to guide clinical therapyThe role of risk score model in chemotherapy and targeted therapy. The correlation between risk scores and IC50 value of paclitaxel (A), gemcitabine (C), etoposide (E), and erlotinib (G); The drug response of paclitaxel (B), gemcitabine (D), etoposide (F), and erlotinib (H) between the higher-risk and lower-risk groupsBack to article page